The European Technology Platform on Nanomedicine (ETPN) is pleased to officially announce the election of Laurent Lévy, CEO and founder of Nanobiotix, as the new Chairman of its Executive Board. This election took place during the General Assembly on May 27th, 2025, hosted at the prestigious Aula Magna of the University of Barcelona, marking the start of the NME25 Conference and celebrating 20 years of European nanomedicine innovation.
Laurent Lévy succeeds Professor Raymond Schiffelers, whose impactful four-year tenure has significantly reinforced ETPN’s strategic role and visibility within the European health innovation ecosystem. Under Laurent’s leadership, the newly elected Executive Board will pursue an ambitious strategic program, “Expanding Legacy,” aiming to enhance the ETPN’s impact, continuity, and growth.
Key priorities for the new mandate include:
- Strategic Advocacy: Reinforcing the ETPN’s influential voice with European institutions and policymakers.
- Empowering Members & Community: Providing enhanced networking opportunities and tailored operational support.
- Accelerating Clinical Translation: Scaling up the successful HealthTech Translation Advisory Board (TAB) to further advance promising nanomedicine projects towards the clinic.
- Mentorship & Talent Development: Intensifying support for early-career researchers via the ETPN Academy.
- Collaborative Projects & Sustainable Growth: Deepening strategic involvement in major EU-funded projects such as METRINO and NANOSPRESSO.
Laurent Lévy shared his vision and enthusiasm:
“Returning to the ETPN Board as Chairman is both an honor and a strong commitment. I deeply believe we can build upon ETPN’s legacy to effectively accelerate tangible nanomedicine innovations from laboratory to clinical practice. With our dedicated team, engaged community, and the extensive family of ETPN members, we will continue to advance nanomedicine to benefit patients across Europe. Everyone working to improve patients’ lives through nanotechnologies is warmly invited to join us in this exciting journey!”
Meet the complete Executive Board (2025–2027):
Chairman: Laurent Lévy (Nanobiotix, France)
Vice-Chairs:
- Lorena Diéguez (INL, Portugal)
- Furio Gramatica (Fondazione Don Gnocchi, Italy)
Treasurer: Alexandre Superville (Jedha, France)
Secretary: Giovanni Tosi (University of Modena & Reggio Emilia, Italy)
Working Groups Chairs:
- Nanotherapeutics: Andreas Åslund (SINTEF, Norway)
- Medical Devices: Iraida Loinaz (CIDETEC, Spain)
- Regenerative Medicine: Ana Paula Pêgo (i3S Porto, Portugal)
- Safety & Characterization: Neill Liptrott (University of Liverpool, UK)
- Clinical Translation: Marzia Bedoni (Fondazione Don Gnocchi, Italy)
- Education & Training: Marco Monopoli (RCSI, Ireland)
- Business Opportunities: Pedro Silva (Gulbenkian Institute, Portugal)
- Regulatory Compliance: Luigi Calzolai (JRC, European Commission, Italy)
This outstanding European leadership team, combining renewed commitment and fresh perspectives, positions the ETPN ideally for a strong mandate period. The process of nominationf the WG vice-chairs is still ongoing. Staty tuned!
Successful kickoff for the new Executive Board
The newly elected ETPN Executive Board recently held its very first meeting, and the energy was simply fantastic: enthusiastic, determined, and fully action-oriented!
Highlights of our first Board meeting:
- Strong momentum: Despite a busy summer period, our new Board members are energized, motivated, and ready to act.
- Action-oriented approach: We’ve already set concrete strategic initiatives in motion, notably reshaping our traditional Working Groups into agile, efficient “Strategic Action Tracks“ to directly address the needs of our community.
- Community-driven agenda: The valuable feedback collected during our recent Members Forum at NME25 in Barcelona actively informs our strategic roadmap.
- Record-breaking NME25: With more than 400 participants, over 250 abstracts submitted, and overwhelmingly positive feedback on scientific sessions and networking opportunities, our Nanomed Europe 2025, 20th anniversary Barcelona event set an exceptionally high standard for future ETPN meetings.
We look forward to sharing further updates very soon, including upcoming webinars, community engagement opportunities, and detailed strategic actions resulting from your direct input.
Stay connected, stay involved—together, we’ll continue building the future of nanomedicine in Europe!
Thank you for your continued support and engagement!